Latest Leads Find out the latest leads from our Book of Lists.
Although this is supposed to be a banner year for venture capital to sink big bucks into biotech, Mendel Biotechnology realized it was at least two years away from satisfying investor questions about a new project it wants to commercialize. Still, Mendel Vice President William Goure and senior scientist James Zhang flirted with about a dozen companies with its plans and, in a few cases, actually approached them. Get your own subscription. Hire East Bay Lots of job opportunities. New businesses, homeowners.